A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

Overview of attention for article published in Investigational New Drugs, August 2004

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS

Application EP-3075247-A1

European Patent Office